CD28 and head and neck squamous cell carcinoma: The results demonstrated that PHLDB2 knockdown cells were more susceptible to CD3/CD28-activated human T cell-induced killing, as indicated by the elevated percentage of cleaved caspase-3+ HNSCC cells compared to the control group (Figure 5C,D).